Safety of Cardiac Pacemakers in 3 Tesla MRI

Overview

To evaluate short-term and long-term effects by MR imaging at 3T on the technical and functional status of cardiac pacemakers.

Full Title of Study: “Study to Evaluate Safety of Cardiac Pacemakers in MR Imaging at 3T Tesla”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective

Detailed Description

Recently, a shift could be observed from cardiac pacemakers being an absolute contraindication to being a relative contraindication for MR imaging at 1.5 Tesla, depending on a patient-per-patient risk-benefit-evaluation, which includes an urgent clinical need for MR imaging (other imaging modalities non-conclusive) and co-morbidities (especially cardiac co-morbidities). At the same time, MR imaging at 3 Tesla is evolving from a research application only to an important imaging modality today. Using the improved signal-to-noise-ratio, high field MR-Systems with a field strength of 3 Tesla offer a variety of diagnostic advantages to 1.5 Tesla systems. These advantages lead to a higher sensitivity and specificity in diagnosing, foremost neurological, disorders. In this study, we evaluate the safety of MR imaging of the brain in patients with cardiac pacemakers at 3T.

Participating in This Clinical Trial

Inclusion Criteria

  • Urgent need for an MRI examination – Stable pacemaker physical parameters – Battery voltage > 2.7 V – Battery impedance < 2000 Ohm – Battery estimated remaining lifetime > 6 months – Lead impedances 200-2000 Ohm – Stable pacing parameters – Pacing capture threshold <2.5V at a pulse duration of 0.4ms – Sensing > 5mV – Minimum 3 months since pacemaker and lead implantation Exclusion Criteria:

  • History of ventricular tachycardia (VT) or ventricular fibrillation – Unstable angina – Myocardial infarction within the previous 3 months – Cardiothoracic surgery within the previous 3 months – Presence of an abdominal pacemaker with lead length > 70 cm – Presence of MRI incompatible bioimplants or other MRI incompatible materials

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Bonn
  • Overall Official(s)
    • Torsten Sommer, MD, Principal Investigator, University of Bonn, Department of Radiology
  • Overall Contact(s)
    • Torsten Sommer, MD, +49-163-6113875, t.sommer@uni-bonn.de

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.